COR-101

· Corat Therapeutics Gmbh

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for COR-101, covering 2022-05-25 to 2022-05-25. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Safety and Tolerability of COR-101 in Hospitalized Patients With Moderate to Severe COVID-19 [Phase 1, Phase 2]

See pricing